DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Fuchs CS, Tomasek J, Yong CJ et al. REGARD Trial Investigators.
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet 2014;
383: 31-39
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.